Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read MorePosted by Steve Halasey | Nov 9, 2018 | Disease States, Leukemia, Lymphoma, Molecular Diagnostics |
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read MorePosted by Steve Halasey | Nov 7, 2018 | Melanoma |
The partners will apply deep machine learning to develop biomarker models for relevant treatment-associated endpoints such as immune-related adverse events, clinical response, or survival.
Read MorePosted by Melissa Mayer | Oct 28, 2018 | Lung Cancer |
Liquid biopsy test identifies 70 of the most commonly mutated genes in solid tumors as well as microsatellite instability.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Research |
Clinical data suggest the potential utility of multiplex panels capable of moving commonly requested blood tests from laboratory settings into the community for point-of-care application.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Infectious Diseases, Molecular Diagnostics, Point-of-Care |
Enables hepatitis C point-of-care molecular testing and linkage to care.
Read More